Significant Ownership of New Enterprise Associates 16, L.P.

Signature - Title
/s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by New Enterprise Associates 16, L.P..

Notify me when New Enterprise Associates 16, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of New Enterprise Associates 16, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TRVI Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share 12% $170,186,363 15,074,080 0% New Enterprise Associates 16, L.P. 07 Aug 2025
MRKR Marker Therapeutics, Inc. Common Stock, par value $0.001 per share 9.9% $1,703,483 +$45,291 1,670,081 +2.7% New Enterprise Associates 16, L.P. 13 Nov 2025
ALLK Allakos Inc. Common Stock, par value $0.001 0% $0 0 New Enterprise Associates 16, L.P. 15 May 2025

Schedules 13D/G Reported by New Enterprise Associates 16, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.